Cipla acquires nutrition products’ portfolio from Wanbury

10 Feb 2020 Evaluate

Cipla has acquired nutrition products’ portfolio from Wanbury. The company has acquired 4 brands-CPink, CDense, Productiv and Folinine to further strengthen its presence in women’s health.

The nutraceutical products, to be sold under the 4 umbrella brands, would address various health needs for conditions arising due to nutritional deficiencies or insufficiencies. This includes supplements such as multivitamins, multimineral and antioxidants for adolescent girls, pregnant and lactating women, women going through menopause and for male and female reproductive health.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients.

Cipla Share Price

1317.80 -2.55 (-0.19%)
30-Jan-2026 11:41 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1587.60
Dr. Reddys Lab 1221.90
Cipla 1317.80
Zydus Lifesciences 886.50
Lupin 2134.50
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×